These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 39406907)
61. Mesenchymal stem cells-macrophages crosstalk and myeloid malignancy. Li K; Nie H; Jin R; Wu X Front Immunol; 2024; 15():1397005. PubMed ID: 38779660 [TBL] [Abstract][Full Text] [Related]
62. Exosome-mediated communication between tumor cells and tumor-associated macrophages: implications for tumor microenvironment. Han C; Zhang C; Wang H; Zhao L Oncoimmunology; 2021 Feb; 10(1):1887552. PubMed ID: 33680573 [TBL] [Abstract][Full Text] [Related]
63. APOE expression in papillary thyroid carcinoma: Influencing tumor progression and macrophage polarization. Huo R; Zhao R; Li Z; Li M; Bin Y; Wang D; Xue G; Wu J; Lin X Immunobiology; 2024 Sep; 229(5):152821. PubMed ID: 38935988 [TBL] [Abstract][Full Text] [Related]
64. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation. Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475 [TBL] [Abstract][Full Text] [Related]
65. Guardians and Mediators of Metastasis: Exploring T Lymphocytes, Myeloid-Derived Suppressor Cells, and Tumor-Associated Macrophages in the Breast Cancer Microenvironment. Ruocco MR; Gisonna A; Acampora V; D'Agostino A; Carrese B; Santoro J; Venuta A; Nasso R; Rocco N; Russo D; Cavaliere A; Altobelli GG; Masone S; Avagliano A; Arcucci A; Fiume G Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892411 [TBL] [Abstract][Full Text] [Related]
66. LncRNA-HOXC-AS2 regulates tumor-associated macrophage polarization through the STAT1/SOCS1 and STAT1/CIITA pathways to promote the progression of non-small cell lung cancer. Yin C; Li J; Li S; Yang X; Lu Y; Wang C; Liu B Cell Signal; 2024 Mar; 115():111031. PubMed ID: 38168631 [TBL] [Abstract][Full Text] [Related]
67. Exosomal MicroRNAs as Mediators of Cellular Interactions Between Cancer Cells and Macrophages. Kwon Y; Kim M; Kim Y; Jung HS; Jeoung D Front Immunol; 2020; 11():1167. PubMed ID: 32595638 [TBL] [Abstract][Full Text] [Related]
68. Exosome-mediated communication between gastric cancer cells and macrophages: implications for tumor microenvironment. Qiu Y; Lu G; Li N; Hu Y; Tan H; Jiang C Front Immunol; 2024; 15():1327281. PubMed ID: 38455041 [TBL] [Abstract][Full Text] [Related]
69. The FKBP51s Splice Isoform Predicts Unfavorable Prognosis in Patients with Glioblastoma. Giordano C; Marrone L; Romano S; Della Pepa GM; Donzelli CM; Tufano M; Capasso M; Lasorsa VA; Quintavalle C; Guerri G; Martucci M; Auricchio A; Gessi M; Sala E; Olivi A; Romano MF; Gaudino S Cancer Res Commun; 2024 May; 4(5):1296-1306. PubMed ID: 38651817 [TBL] [Abstract][Full Text] [Related]
70. The role of tumor-associated macrophages in osteosarcoma progression - therapeutic implications. Huang Q; Liang X; Ren T; Huang Y; Zhang H; Yu Y; Chen C; Wang W; Niu J; Lou J; Guo W Cell Oncol (Dordr); 2021 Jun; 44(3):525-539. PubMed ID: 33788151 [TBL] [Abstract][Full Text] [Related]
71. Tumor-associated macrophages employ immunoediting mechanisms in colorectal tumor progression: Current research in Macrophage repolarization immunotherapy. Cheruku S; Rao V; Pandey R; Rao Chamallamudi M; Velayutham R; Kumar N Int Immunopharmacol; 2023 Mar; 116():109569. PubMed ID: 36773572 [TBL] [Abstract][Full Text] [Related]
72. Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted Drugs. Cresswell GM; Wang B; Kischuk EM; Broman MM; Alfar RA; Vickman RE; Dimitrov DS; Kularatne SA; Sundaram CP; Singhal S; Eruslanov EB; Crist SA; Elzey BD; Ratliff TL; Low PS Cancer Res; 2021 Feb; 81(3):671-684. PubMed ID: 33203700 [TBL] [Abstract][Full Text] [Related]
73. Biological impact and therapeutic implication of tumor-associated macrophages in hepatocellular carcinoma. Li D; Zhang T; Guo Y; Bi C; Liu M; Wang G Cell Death Dis; 2024 Jul; 15(7):498. PubMed ID: 38997297 [TBL] [Abstract][Full Text] [Related]
74. Targeting the Depletion of M2 Macrophages: Implication in Cancer Immunotherapy. Festekdjian T; Bonavida B Crit Rev Oncog; 2024; 29(4):55-73. PubMed ID: 38989738 [TBL] [Abstract][Full Text] [Related]
75. M2-type tumor-associated macrophages upregulated PD-L1 expression in cervical cancer via the PI3K/AKT pathway. Guo F; Kong W; Li D; Zhao G; Anwar M; Xia F; Zhang Y; Ma C; Ma X Eur J Med Res; 2024 Jul; 29(1):357. PubMed ID: 38970071 [TBL] [Abstract][Full Text] [Related]
76. Macrophage Biology and Mechanisms of Immune Suppression in Breast Cancer. Mehta AK; Kadel S; Townsend MG; Oliwa M; Guerriero JL Front Immunol; 2021; 12():643771. PubMed ID: 33968034 [TBL] [Abstract][Full Text] [Related]
77. Macrophages in tumor: An inflammatory perspective. Goswami KK; Bose A; Baral R Clin Immunol; 2021 Nov; 232():108875. PubMed ID: 34740843 [TBL] [Abstract][Full Text] [Related]
78. Tumor-associated macrophages as a potential therapeutic target in thyroid cancers. Zhu L; Li XJ; Gangadaran P; Jing X; Ahn BC Cancer Immunol Immunother; 2023 Dec; 72(12):3895-3917. PubMed ID: 37796300 [TBL] [Abstract][Full Text] [Related]
79. CD44v5 domain regulates crosstalk between TNBC cells and tumor-associated macrophages by enhancing the IL-4R/STAT3 axis. Dai Y; Ji Z; Liang H; Jiang M; Wang L; Bao X; Liu J; Liu M; Yang C Cancer Sci; 2024 Jul; 115(7):2235-2253. PubMed ID: 38700108 [TBL] [Abstract][Full Text] [Related]
80. Targeting tumor-associated macrophages: A potential treatment for solid tumors. Chen Y; Jin H; Song Y; Huang T; Cao J; Tang Q; Zou Z J Cell Physiol; 2021 May; 236(5):3445-3465. PubMed ID: 33200401 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]